Actively Recruiting
Studying TIPS Treatment in Adults with Complicated Portal Hypertension from Porto-Sinusoidal Vascular Disease Compared to Cirrhosis
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-11-19
360
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the use of Transjugular Intrahepatic Portosystemic Shunt TIPS in patients with Porto-Sinusoidal Vascular Disease PSVD, a rare condition causing portal hypertension without cirrhosis. This condition can lead to serious complications like digestive bleeding, ascites, or portal vein thrombosis. The study compares outcomes of TIPS in PSVD patients to those in patients with cirrhosis-related portal hypertension to better understand when and how TIPS should be used. This is a retrospective, multicenter observational study involving expert French university centers. It compares a group of PSVD patients who received TIPS with a matched historical group of cirrhosis patients who had TIPS, based on age, sex, and indication for the procedure. No new treatments will be given, and the study observes real-life outcomes. Participants survival after TIPS placement will be assessed at multiple time points ranging from 3 months to 5 years. Researchers will also monitor recurrence of portal hypertension complications, TIPS dysfunction, and any procedure-related complications during these periods. The study aims to provide detailed data on the safety, tolerance, and timing of TIPS in PSVD compared to cirrhosis.
CONDITIONS
Brief Title
TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease
Research Team
E
Eric NGUYEN-KHAC, Pr
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here